More than a sidekick: The IL-6 family cytokine IL-11 links inflammation to cancer

Journal of Leukocyte Biology

Volumn 88, Issue 6, 2010, Pages 1109-1117

  Putoczki, Tracy ^a   Ernst, Matthias ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Epithelium; Interleukin; Mouse models

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 11 MUTEIN; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 11 RECEPTOR ALPHA; INTERLEUKIN 6; STAT3 PROTEIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CANCER GROWTH; COLON CANCER; CYTOKINE PRODUCTION; EPITHELIUM CELL; HEMATOPOIETIC CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; NEOPLASM; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANIMALS; CYTOKINE RECEPTOR GP130; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-11; NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 78649744885     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0410226     Document Type: Review

References (94)

1. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081.
2. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., Karin, M. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103-113.
3. Park, E. J., Lee, J. H., Yu, G. Y., He, G., Ali, S. R., Holzer, R. G., Osterreicher, C. H., Takahashi, H., Karin, M. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208.
4. Bromberg, J. (2002) Stat proteins and oncogenesis. J. Clin. Invest. 109, 1139-1142.
5. Ernst, M., Najdovska, M., Grail, D., Lundgren-May, T., Buchert, M., Tye, H., Matthews, V. B., Armes, J., Bhathal, P. S., Hughes, N. R., Marcusson, E. G., Karras, J. G., Na, S., Sedgwick, J. D., Hertzog, P. J., Jenkins, B. J. (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Invest. 118, 1727-1738.
6. Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., Ciliberto, G. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187, 461-468.
7. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H., Fontana, A. (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178-2187.
8. Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., Becker, C. (2007) Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J. Immunol. 179, 2041-2045.
9. Matadeen, R., Hon, W. C., Heath, J. K., Jones, E. Y., Fuller, S. (2007) The dynamics of signal triggering in a gp130-receptor complex. Structure 15, 441-448.
10. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G., Schaper, F. (2003) Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem. J. 374, 1-20. (Pubitemid 37046923)
11. Tebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., Heath, J. K., Ernst, M. (2002) Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8, 1089-1097.
12. Levy, D. E., Lee, C. K. (2002) What does Stat3 do? J. Clin. Invest. 109, 1143-1148.
13. Schwertschlag, U. S., Trepicchio, W. L., Dykstra, K. H., Keith, J. C., Turner, K. J., Dorner, A. J. (1999) Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 13, 1307-1315.
14. Maier, R., Ganu, V., Lotz, M. (1993) Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J. Biol. Chem. 268, 21527-21532.
15. Suen, Y., Chang, M., Lee, S. M., Buzby, J. S., Cairo, M. S. (1994) Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84, 4125-4134.
16. Elias, J. A., Tang, W., Horowitz, M. C. (1995) Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136, 489-498.
17. Zheng, T., Zhu, Z., Wang, J., Homer, R. J., Elias, J. A. (2001) IL-11: insights in asthma from overexpression transgenic modeling. J. Allergy Clin. Immunol. 108, 489-496.
18. Einarsson, O., Geba, G. P., Zhu, Z., Landry, M., Elias, J. A. (1996) Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97, 915-924.
19. Walmsley, M., Butler, D. M., Marinova-Mutafchieva, L., Feldmann, M. (1998) An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis. Immunology 95, 31-37.
20. Hanavadi, S., Martin, T. A., Watkins, G., Mansel, R. E., Jiang, W. G. (2006) Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann. Surg. Oncol. 13, 802-808.
21. Sales, K. J., Grant, V., Cook, I. H., Maldonado-Perez, D., Anderson, R. A., Williams, A. R., Jabbour, H. N. (2010) Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2α-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. Am. J. Pathol. 176, 435-445.
22. Campbell, C. L., Guardiani, R., Ollari, C., Nelson, B. E., Quesenberry, P. J., Savarese, T. M. (2001) Interleukin-11 receptor expression in primary ovarian carcinomas. Gynecol. Oncol. 80, 121-127.
23. Campbell, C. L., Jiang, Z., Savarese, D. M., Savarese, T. M. (2001) Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am. J. Pathol. 158, 25-32.
24. Nakayama, T., Yoshizaki, A., Izumida, S., Suehiro, T., Miura, S., Uemura, T., Yakata, Y., Shichijo, K., Yamashita, S., Sekin, I. (2007) Expression of interleukin-11 (IL-11) and IL-11 receptor α in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int. J. Oncol. 30, 825-833.
25. Davidson, A. J., Freeman, S. A., Crosier, K. E., Wood, C. R., Crosier, P. S. (1997) Expression of murine interleukin 11 and its receptor α-chain in adult and embryonic tissues. Stem Cells 15, 119-124.
26. Romas, E., Udagawa, N., Zhou, H., Tamura, T., Saito, M., Taga, T., Hilton, D. J., Suda, T., Ng, K. W., Martin, T. J. (1996) The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. 183, 2581-2591.
27. Robb, L., Hilton, D. J., Brook-Carter, P. T., Begley, C. G. (1997) Identification of a second murine interleukin-11 receptor α-chain gene (IL11Ra2) with a restricted pattern of expression. Genomics 40, 387-394.
28. Rose-John, S., Heinrich, P. C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
29. Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., Maihle, N. J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96-100.
30. Baumann, H., Wang, Y., Morella, K. K., Lai, C. F., Dams, H., Hilton, D. J., Hawley, R. G., Mackiewicz, A. (1996) Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J. Immunol. 157, 284-290. (Pubitemid 26190559)
31. Curtis, D. J., Hilton, D. J., Roberts, B., Murray, L., Nicola, N., Begley, C. G. (1997) Recombinant soluble interleukin-11 (IL-11) receptor α-chain can act as an IL-11 antagonist. Blood 90, 4403-4412.
32. Neddermann, P., Graziani, R., Ciliberto, G., Paonessa, G. (1996) Functional expression of soluble human interleukin-11 (IL-11) receptor α and stoichiometry of in vitro IL-11 receptor complexes with gp130. J. Biol. Chem. 271, 30986-30991.
33. Dahmen, H., Horsten, U., Kuster, A., Jacques, Y., Minvielle, S., Kerr, I. M., Ciliberto, G., Paonessa, G., Heinrich, P. C., Muller-Newen, G. (1998) Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem. J. 331, 695-702.
34. Moodley, Y. P., Misso, N. L., Scaffidi, A. K., Fogel-Petrovic, M., McAnulty, R. J., Laurent, G. J., Thompson, P. J., Knight, D. A. (2003) Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am. J. Respir. Cell Mol. Biol. 29, 490-498.
35. Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara Jr., R. M., Leary, A. C., Sibley, B., Clark, S. C., Williams, D. A., et al. (1990) Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87, 7512-7516. (Pubitemid 20341746)
36. Cantor, S. B., Elting, L. S., Hudson Jr., D. V., Rubenstein, E. B. (2003) Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer 97, 3099-3106.
37. Du, X. X., Williams, D. A. (1994) Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83, 2023-2030.
38. Weich, N. S., Wang, A., Fitzgerald, M., Neben, T. Y., Donaldson, D., Giannotti, J., Yetz-Aldape, J., Leven, R. M., Turner, K. J. (1997) Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 90, 3893-3902.
39. Du, X., Everett, E. T., Wang, G., Lee, W. H., Yang, Z., Williams, D. A. (1996) Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J. Cell. Physiol. 168, 362-372.
40. Musashi, M., Yang, Y. C., Paul, S. R., Clark, S. C., Sudo, T., Ogawa, M. (1991) Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc. Natl. Acad. Sci. USA 88, 765-769.
41. Musashi, M., Clark, S. C., Sudo, T., Urdal, D. L., Ogawa, M. (1991) Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78, 1448-1451.
42. Holyoake, T. L., Freshney, M. G., McNair, L., Parker, A. N., McKay, P. J., Steward, W. P., Fitzsimons, E., Graham, G. J., Pragnell, I. B. (1996) Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 87, 4589-4595.
43. Yin, T. G., Schendel, P., Yang, Y. C. (1992) Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J. Exp. Med. 175, 211-216.
44. Nandurkar, H. H., Robb, L., Begley, C. G. (1998) The role of IL-11 in hematopoiesis as revealed by a targeted mutation of its receptor. Stem Cells 16 (Suppl. 2), 53-65.
45. Du, X., Williams, D. A. (1997) Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89, 3897-3908.
46. Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Keith Jr., J. C., Brinson, Y. S., Bungard, D., Ferrara, J. L. (1998) Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest. 102, 115-123. (Pubitemid 28323837)
47. Qiu, B. S., Pfeiffer, C. J., Keith Jr., J. C. (1996) Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig. Dis. Sci. 41, 1625-1630.
48. Sonis, S., Muska, A., O'Brien, J., Van Vugt, A., Langer-Safer, P., Keith, J. (1995) Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur. J. Cancer B Oral Oncol. 31B, 261-266.
49. Du, X., Liu, Q., Yang, Z., Orazi, A., Rescorla, F. J., Grosfeld, J. L., Williams, D. A. (1997) Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am. J. Physiol. 272, G545-G552.
50. Castagliuolo, I., Kelly, C. P., Qiu, B. S., Nikulasson, S. T., LaMont, J. T., Pothoulakis, C. (1997) IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum. Am. J. Physiol. 273, G333-G341.
51. Waxman, A. B., Einarsson, O., Seres, T., Knickelbein, R. G., Warshaw, J. B., Johnston, R., Homer, R. J., Elias, J. A. (1998) Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101, 1970-1982.
52. Lee, C. G., Hartl, D., Matsuura, H., Dunlop, F. M., Scotney, P. D., Fabri, L. J., Nash, A. D., Chen, N. Y., Tang, C. Y., Chen, Q., Homer, R. J., Baca, M., Elias, J. A (2008) Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am. J. Respir. Cell Mol. Biol. 39, 739-746.
53. Henson, P. M., Riches, D. W. (1994) Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation. Ann. N. Y. Acad. Sci. 725, 298-308.
54. Trepicchio, W. L., Wang, L., Bozza, M., Dorner, A. J. (1997) IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J. Immunol. 159, 5661-5670.
55. Ellis, M., Hedstrom, U., Frampton, C., Alizadeh, H., Kristensen, J., Shammas, F. V., al-Ramadi, B. K. (2006) Modulation of the systemic inflammatory response by recombinant human interleukin-11: a prospective randomized placebo controlled clinical study in patients with hematological malignancy. Clin. Immunol. 120, 129-137.
56. Bozza, M., Bliss, J. L., Dorner, A. J., Trepicchio, W. L. (2001) Interleukin- 11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J. Interferon Cytokine Res. 21, 21-30.
57. Chen, Q., Rabach, L., Noble, P., Zheng, T., Lee, C. G., Homer, R. J., Elias, J. A. (2005) IL-11 receptor α in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 174, 2305-2313.
58. Curti, A., Ratta, M., Corinti, S., Girolomoni, G., Ricci, F., Tazzari, P., Siena, M., Grande, A., Fogli, M., Tura, S., Lemoli, R. M. (2001) Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 97, 2758-2763.
59. Bamba, S., Andoh, A., Yasui, H., Makino, J., Kim, S., Fujiyama, Y. (2003) Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G529-G538.
60. Andoh, A., Zhang, Z., Inatomi, O., Fujino, S., Deguchi, Y., Araki, Y., Tsujikawa, T., Kitoh, K., Kim-Mitsuyama, S., Takayanagi, A., Shimizu, N., Fujiyama, Y. (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129, 969-984.
61. Shi, X. Z., Sarna, S. K. (2005) Transcriptional regulation of inflammatory mediators secreted by human colonic circular smooth muscle cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G274-G284.
62. Singh, B., Berry, J. A., Shoher, A., Lucci, A. (2006) COX-2 induces IL-11 production in human breast cancer cells. J. Surg. Res. 131, 267-275.
63. Orazi, A., Du, X., Yang, Z., Kashai, M., Williams, D. A. (1996) Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Invest. 75, 33-42.
64. Kiessling, S., Muller-Newen, G., Leeb, S. N., Hausmann, M., Rath, H. C., Strater, J., Spottl, T., Schlottmann, K., Grossmann, J., Montero-Julian, F. A., Scholmerich, J., Andus, T., Buschauer, A., Heinrich, P. C., Rogler, G. (2004) Functional expression of the interleukin-11 receptor α-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J. Biol. Chem. 279, 10304-10315.
65. Potten, C. S. (1996) Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 14, 452-459.
66. Boerma, M., Wang, J., Burnett, A. F., Santin, A. D., Roman, J. J., Hauer-Jensen, M. (2007) Local administration of interleukin-11 ameliorates intestinal radiation injury in rats. Cancer Res. 67, 9501-9506. (Pubitemid 47535940)
67. Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, O., Schwitalla, S., Matthews, V., Schmid, R. M., Kirchner, T., Arkan, M. C., Ernst, M., Greten, F. R. (2009) gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91-102.
68. Mahboubi, K., Biedermann, B. C., Carroll, J. M., Pober, J. S. (2000) IL-11 activates human endothelial cells to resist immune-mediated injury. J. Immunol. 164, 3837-3846.
69. Ernst, M., Jenkins, B. J. (2004) Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet. 20, 23-32.
70. Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., Baumann, H., Judd, L. M., Giraud, A. S., Boussioutas, A., Zhu, H. J., Ernst, M. (2005) Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat. Med. 11, 845-852.
71. Judd, L. M., Alderman, B. M., Howlett, M., Shulkes, A., Dow, C., Moverley, J., Grail, D., Jenkins, B. J., Ernst, M., Giraud, A. S. (2004) Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126, 196-207.
72. Houghton, J., Wang, T. C. (2005) Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128, 1567-1578.
73. Bowman, T., Garcia, R., Turkson, J., Jove, R. (2000) STATs in oncogenesis. Oncogene 19, 2474-2488.
74. Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S., Wingren, C., Borrebaeck, C. A. (2006) Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 5, 1638-1646.
75. Kortylewski, M., Xin, H., Kujawski, M., Lee, H., Liu, Y., Harris, T., Drake, C., Pardoll, D., Yu, H. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15, 114-123.
76. Hodge, D. R., Hurt, E. M., Farrar, W. L. (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41, 2502-2512.
77. Grivennikov, S., Karin, M. (2008) Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13, 7-9.
78. Lewis, V. O., Ozawa, M. G., Deavers, M. T., Wang, G., Shintani, T., Arap, W., Pasqualini, R. (2009) The interleukin-11 receptor α as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res. 69, 1995-1999.
79. Lacroix, M., Siwek, B., Marie, P. J., Body, J. J. (1998) Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett. 127, 29-35.
80. Yoshizaki, A., Nakayama, T., Yamazumi, K., Yakata, Y., Taba, M., Sekine, I. (2006) Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells. Int. J. Oncol. 29, 869-876.
81. Yamazumi, K., Nakayama, T., Kusaba, T., Wen, C. Y., Yoshizaki, A., Yakata, Y., Nagayasu, T., Sekine, I. (2006) Expression of interleukin-11 and interleukin-11 receptor α in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J. Gastroenterol. 12, 317-321.
82. Bellone, G., Smirne, C., Mauri, F. A., Tonel, E., Carbone, A., Buffolino, A., Dughera, L., Robecchi, A., Pirisi, M., Emanuelli, G. (2006) Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol. Immunother. 55, 684-698.
83. Zurita, A. J., Troncoso, P., Cardo-Vila, M., Logothetis, C. J., Pasqualini, R., Arap, W. (2004) Combinatorial screenings in patients: the interleukin-11 receptor α as a candidate target in the progression of human prostate cancer. Cancer Res. 64, 435-439.
84. Meng, L., Zhou, J., Sasano, H., Suzuki, T., Zeitoun, K. M., Bulun, S. E. (2001) Tumor necrosis factor α and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ: mechanism of desmoplastic reaction. Cancer Res. 61, 2250-2255.
85. Judd, L. M., Bredin, K., Kalantzis, A., Jenkins, B. J., Ernst, M., Giraud, A. S. (2006) STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131, 1073-1085.
86. Judd, L. M., Ulaganathan, M., Howlett, M., Giraud, A. S. (2009) Cytokine signaling by gp130 regulates gastric mucosal healing after ulceration and indirectly, antral tumor progression. J. Pathol. 217, 552-562.
87. Ropeleski, M. J., Tang, J., Walsh-Reitz, M. M., Musch, M. W., Chang, E. B. (2003) Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 124, 1358-1368.
88. Suman, P., Poehlmann, T. G., Prakash, G. J., Markert, U. R., Gupta, S. K. (2009) Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J. Reprod. Immunol. 82, 1-11.
89. Sotiriou, C., Lacroix, M., Lespagnard, L., Larsimont, D., Paesmans, M., Body, J. J. (2001) Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett. 169, 87-95.
90. Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., Huang, D. C., Kile, B. T. (2007) Programmed anuclear cell death delimits platelet life span. Cell 128, 1173-1186.
91. Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., Serrano, M. (2007) Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res. 67, 7350-7357.
92. Underhill-Day, N., McGovern, L. A., Karpovich, N., Mardon, H. J., Barton, V. A., Heath, J. K. (2003) Functional characterization of W147A: a high-affinity interleukin-11 antagonist. Endocrinology 144, 3406-3414.
93. Robb, L., Li, R., Hartley, L., Nandurkar, H. H., Koentgen, F., Begley, C. G. (1998) Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat. Med. 4, 303-308. (Pubitemid 28144088)
94. Menkhorst, E., Salamonsen, L., Robb, L., Dimitriadis, E. (2009) IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice. Biol. Reprod. 80, 920-927.